tbuckley/cabot-search huggingface dataset:
NCCN Roundtable: Palliative Care: Providing Comfort From a Patient and Provider Perspective
Journal: Journal of the National Comprehensive Cancer Network (2016)

The words "palliative care" can be threatening for many patients, particularly for those who do not understand what they mean. In fact, according to a survey by the American Cancer Society, about 70% of adults in the United States are not at all knowledgeable about palliative care and how to get it. Often confused with hospice care, palliative care is a rapidly evolving and relatively new specialty focusing on a wide range of issues faced by patients with cancer both during and after treatment. At the NCCN 21st Annual Conference, a distinguished panel assembled to discuss palliative care through the eyes of patients and providers alike. The panel explored some of the barriers to integrating palliative care as well as strategies for overcoming these obstacles to ensure that patients have the opportunity to benefit from the valuable yet often unheralded services provided by palliative care specialists.
PLoS Medicine Issue Image | Vol. 4(7) July 2007
Journal: PLoS Medicine (2007)

The image this month is of Nicotiana tabacum, the plant from which tobacco is made—a surprisingly pretty plant. One of its unpleasant products, snus, a smokeless tobacco, is discussed in a debate article (Gartner, et al.) published in this month's issue, and in the editorial (The PLoS Medicine Editors). Image Credit: Joachim Müllerchen (from http://commons.wikimedia.org/wiki/Image:Tabak_P9290021.JPG)
Reply: Cognitive function and menopausal hormone therapy
Authors: Andrea R. Genazzani
Journal: Human Reproduction Update (2007)

Cognitive function and menopausal hormone therapySir, The subject of cognitive function and the potential role of menopausal hormone therapy (MHT) was addressed by a narrative structured review (Genazzani et al., 2006).This is an important issue, as demographic changes in European populations and worldwide imply that growing numbers of women are potentially prone to the risk of developing cognitive decline including dementia if preventive and therapeutic measures cannot be developed.It is a pity that a Cochrane review on this subject was obviously not considered for this review (Hogervorst et al., 2002).In this systematic review, based on meta-analytic techniques, the authors demonstrated that both estrogen-only (ERT) and estrogenprogestin therapies (EPT) were not beneficial as regards to overall cognitive function of healthy post-menopausal and women with bilateral oophorectomy alike.This review was published before results were available from the Wome's Health
Biliary tract cancer: A large institutional experience.
Authors: Mairead McNamara, Anne M. Horgan, Thomas Walter, Elizabeth McKeever, Trisha Min, David W Hedley, Sean P Cleary, Steven Gallinger, Paul David Greig, Stefano Serra, Jennifer J. Knox
Journal: Journal of Clinical Oncology (2012)

288 Background: Biliary tract cancers (BTCs) encompass both cholangiocarcinoma (CC), arising in the intrahepatic, perihilar (klatskin), or distal biliary tree, ampulla of vater and gallbladder carcinoma (GBC). The prognosis is poor for the majority of these patients (pts). Given the rarity of BTC compared with other solid tumours, there have been few large studies looking at long-term outcomes. The aim of this study was to retrospectively review outcomes of pts who presented to a multidisciplinary team at Princess Margaret Hospital, Toronto, with a diagnosis of BTC. Methods: 950 pts with a diagnosis of BTC were followed from diagnosis to death between Jan 1987 and Sept 2011. Complete demographics, performance status, disease site, histological diagnosis, percentage receiving surgery with curative intent, other treatments and overall survival were analysed. Results: The cohort includes 497 (52%) males, performance status of 0-1 in 781 (82%) and 2-3 in 68 (7%) pts. A histological diagnosis of adenocarcinoma was confirmed in 806 (85%), 104 (11%) were non diagnostic, 40 (4%) other. Definitive surgery was performed in 42% and adjuvant chemotherapy (CT) or concurrent CT/radiotherapy given in only 7% and 4% respectively. The overall survival for the entire cohort of 950 pts was 18 months (mo) with survival for breakdown of tumour type detailed in table. At this time 319 (34%) pts are still alive, 561 (59%) are deceased and status is unknown in 70 (7%). CT or concurrent CT/radiotherapy was given for unresectable or metastatic disease in the first line palliative setting in 332 (35%) and 23 pts (2%) respectively. The response to first line CT in GB was 46% vs. 31% in CC and med survival was 12.2 and 11.2 mo respectively. Conclusions: This represents a large biliary cancer cohort with survival benchmarks obtained in the modern era of multidisciplinary care. The different sub-sites clearly have different prognosis. Responses and survival for advanced disease on CT are similar for GBC and CC. Updated data will be presented. [Table: see text]
Clinical applications of a transcutaneous ultrasonic flow detector
Authors: R. F. Rushmer
Journal: JAMA (1967)

The limits of human perception have been extended enormously by modern technological advances which permit acquisition of quantitative data from outer space or from the submicroscopic realms of atomic nuclei. Engineers employ exquisitely sensitive gauges to analyze the function of machines and components. Meanwhile, physicians still depend heavily on their unaided five senses to obtain clinical data in routine patient care. Recent developments in the use of nondestructive testing techniques for detecting the size, position, displacement, or flow in internal structures of the body provide a preview of things to come in clinical medicine. For example, a small device has been developed for detecting blood-flow velocity in deep and superficial vessels by merely applying a probe to the body surface. This instrument called a transcutaneous Doppler flow detector (Fig 1) is currently being evaluated for its applicability to clinical problems,<sup>1 -3</sup>eg, locating and evaluating arterial occlusions,<sup>4</sup>detecting
Thyroid Disease
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Infectious Disease
Authors: Vincent J. Felitti
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SALUTATORY.
Authors: John B. Hamilton
Journal: JAMA (1889)

"Whoever thinks a faultless piece to see, Thinks what ne'er was, nor is, nor e'er shall be." Pope. In assuming editorial charge of this Journal, I prefer to make no promise now, but to let the manner of performance tell its own story, and take the place of previous promise. I am fully aware of the great responsibilities of the task, and of the great interests of the Association to be upheld byThe Journal; but the fact is recognized that the strong and active coöperation of the members of the oldest, largest and most successful Medical Association of America, will make the work easy, and in proportion to that coöperation,The Journalwill correspondingly benefit the Association. The relative value ofThe Journalto its membership will depend upon the faithfulness with which it mirrors the existing state of medical knowledge as taught and practiced, and I therefore ask
AIDS in Women—United States
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Visages
Authors: Jason D. Eubanks
Journal: Annals of Internal Medicine (2013)

Ad Libitum21 May 2013VisagesJason D. Eubanks, MDJason D. Eubanks, MDFrom University Hospitals Case Medical Center, Cleveland, Ohio.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-158-10-201305210-00022 Audio Reading - “Visages” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Visages," by J.D. Eubanks. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail We pass ... Author, Article, and Disclosure InformationAuthors: Jason D. Eubanks, MDAffiliations: From University Hospitals Case Medical Center, Cleveland, Ohio.Current Author Address: Jason D. Eubanks, MD; e-mail, jdeubanks2002@yahoo.com. PreviousarticleNextarticle Advertisement Audio Reading - “Visages” Audio. Michael A. LaCombe, MD, Annals Associate Editor, reads "Visages," by J.D. Eubanks. Your browser does not support the audio element. Audio player progress bar Step backward in current audio track Play current audio trackPause current audio track Step forward in current audio track Mute current audio trackUnmute current audio track 00:00/ FiguresReferencesRelatedDetails Metrics 21 May 2013Volume 158, Issue 10 Page: 780 Keywords Running ePublished: 21 May 2013 Issue Published: 21 May 2013 Copyright & PermissionsCopyright © 2013 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Cling Peaches
Authors: Terri Kirby Erickson
Journal: JAMA (2009)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BERLIN
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Recovery of Rubella Virus from Army Recruits
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A clinical trial with culturally tailored video to increase participation of African Americans in cancer clinical trials.
Authors: D. R. Banda, M. Mete, R. Kapoor, S. M. Swain
Journal: Journal of Clinical Oncology (2011)

6075 Background: There is a need to develop patient-level interventions to change attitudes and increase African American (AA) participation in cancer clinical trials (CT). This pilot study tests the efficacy of a 15 minute narrative-based video which we created in the first such intervention in AA patients. Methods: This single group, pre/post-test, mixed methods study enrolled cancer patients in active treatment at a large urban cancer institute. Eligible patients were self-identified AA, ≥ 21 years, and never participated in a CT. The primary outcome was self-reported likelihood to enroll in a therapeutic CT. Participants were interviewed at baseline using an instrument developed specifically to assess attitudes on six trial barriers. An immediate post-test was administered following the video. McNemar’s test for matched pairs was used to assess the change in likelihood to enroll in a CT. Stuart-Maxwell marginal homogeneity test for matched pairs with multi-category outcomes was used to evaluate which attitudes were impacted by the intervention. Multivariate logistic regression analysis adjusted for matching baseline variables was used to assess the effect of demographic variables independently of the intervention. Results: Patients enrolled October 2010- January 2011 (n =92), 77% female. Age from 31-87 years, mean 60 (SD=12). Patients’ likelihood of enrolling in a CT significantly increased post video [OR 9.67 , 95% CI: 2.99-49.59 (46% pre and 74% post-test), McNemar’s χ2 = 21.13, p <0.001]. Stuart-Maxwell tests showed significant changes in 27 of 30 attitudinal questions post video. Multivariate logistic regression analyses showed that baseline variables were not significantly associated with greater likelihood to enroll; the inclusion of these matching variables did not change the impact of the intervention (OR=9.9, p=0.001). Conclusions: These data demonstrate the overall efficacy of our video, which should have particular benefit for National Cancer Institute cooperative groups and utility in community-based settings.
Gonorrhea: Being the Translation of Blenorrhea of the Sexual Organs and its Complications.
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Retroperitoneal, Lumbar, and Pelvic Malignancies Simulating the "Disc Syndrome"
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cyclazocine and methadone in narcotic addiction
Authors: A. M. Freedman
Journal: JAMA (1967)

Narcotic addicts volunteered for treatment with methadone hydrochloride and cyclazocine in a community hospital. Eight of 15 addicts treated with methadone have been maintained in the community for more than one year, and their continued contact with the clinic provided a basis for habilitation. Cyclazocine, an experimental narcotic antagonist, was given to 103 patients. In 51, in a prolonged hospitalization "therapeutic community" program, cyclazocine did not augment their treatment. But, cyclazocine was successful in 52 additional patients treated rapidly and hospitalized for less than two months. After discharge, thirty-one attended a clinic three times weekly for two months. Four to 5 mg cyclazocine daily effectively blocked 15 mg intravenous heroin, up to 28 hours. Secondary effects of increased libido, euphoria, constipation, restlessness, and insomnia abated within two weeks. These results are promising, and cyclazocine is worthy of further investigation.
CORRECTION
Journal: Journal of Clinical Investigation (1982)

CHANGE To harvest the cells, the culture medium was poured out, the cells were washed gently with phosphate-buffered saline (PBS), and then detached by addition of a mixture of 0.25% trypsin (Sigma Chemical Co., St. Louis, MO), and 1% (wt/vol) EDTA in PBS for 3 min at 37°C.TO READ To harvest the cells, the culture medium was poured out, the cells were washed gently with phosphate-buffered saline (PBS), and then detached by addition of a mixture of 0.25% trypsin (Sigma Chemical Co., St. Louis, MO), and 0.1% (wt/vol) EDTA in PBS for 3 min at 37°C.